Free Trial

Organogenesis (ORGO) Earnings Date, Estimates & Call Transcripts

Organogenesis logo
$2.90 -0.07 (-2.36%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.95 +0.05 (+1.72%)
As of 05/23/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Organogenesis Earnings Summary

Organogenesis released Q1 2025 earnings on May 8, 2025, reporting an EPS of -$0.13, which missed analysts' consensus estimates of $0.04 by $0.17. Quarterly revenue was reported to be $86.69 million, below analyst estimates of $90.77 million. With a trailing EPS of -$0.17, Organogenesis' earnings are expected to grow next year, from ($0.07) to ($0.04) per share.

Latest Q1
Earnings Date
May. 8Estimated
Consensus EPS
(May. 8)
$0.04
Actual EPS
(May. 8)
-$0.13 Missed By -$0.17
Actual Revenue
(May. 8)
$86.69M

Q1 2025 Earnings Resources

Get Organogenesis Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organogenesis and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ORGO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORGO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Organogenesis Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.07) EPS
Next Year EPS Consensus Estimate
($0.04) EPS

Organogenesis Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025$0.04-$0.13 -$0.17-$0.17$90.77M$86.69M
11/12/2024Q3 2024-$0.02$0.09+$0.11$0.09$109.59M$115.18M
8/8/2024Q2 2024-$0.02-$0.13 -$0.11-$0.13$122.48M$130.23M
5/9/2024Q1 2024-$0.03-$0.02+$0.01-$0.02$100.44M$109.98M
11/9/2023Q3 2023$0.01$0.02+$0.01$0.02$112.75M$108.53M
8/9/2023Q2 2023$0.02$0.04+$0.02$0.04$115.25M$117.32M

Organogenesis Earnings - Frequently Asked Questions

Organogenesis (NASDAQ:ORGO) last announced its quarterly earning data on Thursday, May 8, 2025. Learn more on ORGO's earnings history.

Organogenesis updated its FY 2025 earnings guidance on Thursday, May, 8th. The company issued revenue guidance of $480.0 million-$535.0 million, compared to the consensus revenue estimate of $488.3 million.

In the previous quarter, Organogenesis (NASDAQ:ORGO) missed the analysts' consensus estimate of $0.04 by $0.17 with a reported earnings per share (EPS) of ($0.13). Learn more on analysts' earnings estimate vs. ORGO's actual earnings.

The conference call for Organogenesis's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Organogenesis's latest earnings report can be read online.
Read Transcript

Organogenesis (NASDAQ:ORGO) has a recorded annual revenue of $458.76 million.

Organogenesis (NASDAQ:ORGO) has a recorded net income of $4.95 million. ORGO has generated -$0.17 earnings per share over the last four quarters.

Organogenesis's earnings are expected to grow from ($0.07) per share to ($0.04) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ORGO) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners